Grants Totaling $500,000 for Researchers of AIDS Drugs
By Biotechdaily staff writers
Posted on 11 Jun 2003
A final call to submit applications for its Drug Discovery Development Research Grant Program has been announced by GlaxoSmithKline (GSK, London, UK). Researchers working anywhere in the world toward breakthroughs in HIV/AIDS drug therapies have until July 31, 2003, to apply.Posted on 11 Jun 2003
The one-time research grants range from US$25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including therapies aimed at treating infection, prophylactic vaccines, or microbicides designed to prevent transmission of the virus. Since inception of the program, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat HIV.
Research grant recipients will be announced in September 2003 at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago (IL, USA). The grants will be paid on November 1, 2003. Detailed information as well as an application are available on the grant website (www.dddresearchgrant.com).
GSK >>
Related Links:
GlaxoSmithKline
Grant Info website
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
